Olopatadine Hydrochloride
Product Images NDC 53002-0510

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 53002-0510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (A2432c67 2a64 4710 90c7 Abd0c5a188af 01)

Molecular Structure (A2432c67 2a64 4710 90c7 Abd0c5a188af 01)
Chemical structure of Olopatadine Hydrochloride showing its molecular framework including aromatic rings, side chains, and functional groups such as hydrochloride (HCl) and hydroxyl (OH).*
FDA Label Image

Label Image (Lbl530020510)

Label Image (Lbl530020510)
OLOPATADINE HYDROCHLORIDE 0.1% ophthalmic solution in a 5 mL bottle, labeled by RPK Pharmaceuticals, Inc. The label indicates a dosage of 1 drop into affected eye(s) twice daily at a 6-8 hour interval. The label includes spaces for lot number, expiration date, patient name, and clinic information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.